Real-World Experience Treating Pediatric Epilepsy Patients With Cenobamate
IntroductionIn one third of all patients with epilepsy, seizure freedom is not achieved through anti-seizure medication (ASM). These patients have an increased risk of earlier death, poorer cognitive development, and reduced quality of life. Cenobamate (CNB) has recently been approved as a promising...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2022-07-01
|
| Серія: | Frontiers in Neurology |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fneur.2022.950171/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|